Evidence continues to mount suggesting that GLP-1 drugs like Ozempic and Wegovy may help people cut back on cigarettes, ...

People struggling with many addictions, ranging from opioids to gambling, are reporting similar experiences in clinics, on ...

Research suggests the drugs have potential for prevention and harm reduction in substance use disorders, writes Ziyad Al-Aly People taking glucagon-like peptide-1 (GLP-1) receptor agonists often ...

Vaping, cannabis use, alcohol use, prescription stimulant misuse—these, and other addictive behaviors, affect a substantial number of adolescents in the United States, yet how should clinicians ...

Nearly 50 million people in the United States struggle with substance use disorders, and nearly three in four use more than one substance. People with polysubstance use disorders are more likely than ...

Substance use disorders are rarely, if ever, isolated concerns. Substance use is often a response to unaddressed mental health challenges, trauma, and unmet needs, and should be treated as such.

A large epidemiological study of more than 600,000 veterans with diabetes suggests GLP-1 weight-loss medications may reduce ...

Experts from the University of Alabama at Birmingham provide insight and resources on how substances like drugs and alcohol can impact the brain. The purchase and consumption of alcohol and substances ...

Atlas Behavioral Health provides structured addiction treatment and recovery support programs for individuals and ...

Taking medication for opioid use disorder “can offer an advantage, an often-needed edge,” says Miranda. “It can offer reprieve from the intense cravings and adverse drug withdrawal symptoms that ...